Literature DB >> 10101350

Evaluation of the elderly patient with weakness: an evidence based approach.

W M Chew1, D M Birnbaumer.   

Abstract

Because of the altered physiology of the elderly population, either as a result of aging or as a result of other disease processes, many illnesses may present with features that are either atypical or nonspecific in nature. Difficult and nonspecific complaints such as weakness in an elderly patient must be handled in a judicious, cost-effective, comprehensive, and expeditious manner that benefits both the patient and the emergency department. This article addresses the evaluation of the elderly patient who presents to the ED complaining of weakness.

Entities:  

Mesh:

Year:  1999        PMID: 10101350     DOI: 10.1016/s0733-8627(05)70056-0

Source DB:  PubMed          Journal:  Emerg Med Clin North Am        ISSN: 0733-8627            Impact factor:   2.264


  3 in total

1.  Emergency Presentations With Nonspecific Complaints-the Burden of Morbidity and the Spectrum of Underlying Disease: Nonspecific Complaints and Underlying Disease.

Authors:  Julia Karakoumis; Christian H Nickel; Mark Kirsch; Martin Rohacek; Nicolas Geigy; Beat Müller; Selina Ackermann; Roland Bingisser
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

2.  Drug-related emergency department visits by elderly patients presenting with non-specific complaints.

Authors:  Christian H Nickel; Juliane M Ruedinger; Anna S Messmer; Silke Maile; Arno Peng; Michael Bodmer; Reto W Kressig; Stephan Kraehenbuehl; Roland Bingisser
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2013-03-05       Impact factor: 2.953

3.  Adrenomedullin for Risk Stratification of Emergency Patients With Nonspecific Complaints: An Interventional Multicenter Pilot Study.

Authors:  Christian Hans Nickel; Anna Sarah Messmer; Leyla Ghanim; Julia Ilsemann-Karakoumis; Sven Giersdorf; Sabine Hertel; Susanne Ernst; Nicolas Geigy; Roland Bingisser
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.